These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 5172020)

  • 21. [Electroencephalographic characteristics of the functional state of the brain in patients with diffuse toxic goiter].
    Filinovskaia IG
    Probl Endokrinol Gormonoter; 1965; 11(4):13-21. PubMed ID: 5898900
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diffuse toxic goiter].
    Granovskaia-Tsvetkova AM
    Feldsher Akush; 1984 Sep; 49(9):9-13. PubMed ID: 6568195
    [No Abstract]   [Full Text] [Related]  

  • 23. [Paradoxes of the surgical treatment of toxic goiter].
    Myshkin KI; Bluvshteĭn GA
    Sov Med; 1983; (8):107-9. PubMed ID: 6689087
    [No Abstract]   [Full Text] [Related]  

  • 24. [Diffuse toxic goiter].
    Kotova GA
    Med Sestra; 1984 Jan; 43(1):3-6. PubMed ID: 6560201
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ballistocardiography in patients with diffuse toxic goiter during I-131 treatment].
    Dozorets IuL; Bogdanovich GI; Seleznev LE
    Med Radiol (Mosk); 1969 Aug; 14(8):41-4. PubMed ID: 5396104
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pathogenesis and management of Grave's ophthalmopathy].
    Wierzbowska J; Stankiewicz A
    Klin Oczna; 2002; 104(2):147-53. PubMed ID: 12174459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Endocrine ophthalmopathy].
    Pavlova TL
    Vestn Oftalmol; 1999; 115(6):43-6. PubMed ID: 10665292
    [No Abstract]   [Full Text] [Related]  

  • 28. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
    Wallaschofski H; Kuwert T; Lohmann T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Etiology and pathogenesis of diffuse toxic goiter].
    Spesivtseva VG
    Sov Med; 1985; (8):63-6. PubMed ID: 3840609
    [No Abstract]   [Full Text] [Related]  

  • 30. [The toxic nodular struma: a stepchild of medical progress].
    Studer H; Bürgi H
    Ther Umsch; 1969 Nov; 26(11):640-2. PubMed ID: 5395132
    [No Abstract]   [Full Text] [Related]  

  • 31. [Spontaneous rosette formation reaction as a prognostic test in diffuse toxic goiter before and after surgical treatment].
    Radomskiĭ VT
    Vrach Delo; 1981 Jul; (7):27-9. PubMed ID: 6974429
    [No Abstract]   [Full Text] [Related]  

  • 32. Incidental thyroid carcinoma in patients with Graves' disease.
    Phitayakorn R; McHenry CR
    Am J Surg; 2008 Mar; 195(3):292-7; discussion 297. PubMed ID: 18206132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Management of multinodular non-toxic goiter].
    Petrányi G
    Orv Hetil; 1994 Dec; 135(51):2851-2. PubMed ID: 7838520
    [No Abstract]   [Full Text] [Related]  

  • 34. [The role of mutagenic factors in the development of diffuse toxic goiter].
    Kalinin AP; Sidorova OP; Kamynina TS
    Ter Arkh; 1994; 66(12):77-9. PubMed ID: 7900055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-therapeutic thyroid reserve. Thyroid reserve in euthyroid patients after ablative therapy for diffuse toxic goiter.
    Prendergast JJ; Miller JM
    Henry Ford Hosp Med J; 1970; 18(1):3-10. PubMed ID: 5467196
    [No Abstract]   [Full Text] [Related]  

  • 36. Graves disease in an eight year old boy of Down Syndrome.
    Ahluwalia AI; Narayan S
    Indian Pediatr; 2005 Jan; 42(1):76-7. PubMed ID: 15695868
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
    Bürgi U; Gerber H; Peter HJ
    Schweiz Med Wochenschr; 1995 Aug; 125(31-32):1489-94. PubMed ID: 7545825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of thyrotoxicosis.
    Fisher JN
    South Med J; 2002 May; 95(5):493-505. PubMed ID: 12005006
    [No Abstract]   [Full Text] [Related]  

  • 39. Closing remarks.
    Freedberg AS
    Mayo Clin Proc; 1972 Dec; 47(12):993-5. PubMed ID: 4678379
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of patients with toxic diffuse goiter].
    Spesivtseva VG
    Klin Med (Mosk); 1983 Oct; 61(10):118-23. PubMed ID: 6417398
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.